Literature DB >> 32851556

Evaluation of subclinical retinopathy and angiopathy with OCT and OCTA in patients with systemic lupus erythematosus.

Mehmed Uğur Işık1, Berkay Akmaz2, Fahrettin Akay2, Yusuf Ziya Güven2, Dilek Solmaz3, Önay Gercik3, Gökhan Kabadayı3, İdil Kurut3, Servet Akar3.   

Abstract

PURPOSE: To evaluate the choroidal and retinal layers with optical coherence tomography (OCT) and retinal microvascular structures with optical coherence tomography angiography (OCTA) in systemic lupus erythematosus (SLE) patients.
METHOD: In this prospective, cross-sectional and comparative study, a total of 35 SLE patients and 35 healthy control participants were included. SLE patients who were using hydroxychloroquine (HCQ) and/or immunosuppressive agents are evaluated with OCT and OCTA. SLE patients who have no HCQ maculopathy observed in OCT were included in the patient group.
RESULTS: Mean macular thickness and ganglion cell inner plexiform layer (GC-IPL) thicknesses were thinner in the patient group. When the parameters obtained with OCTA were evaluated, vessel (VD) and perfusion density (PD) were significantly lower in the patient group. Central foveal thickness and foveal avascular zone parameters were negatively correlated. In addition, VD and PD, and GC-IPL thicknesses were positively correlated.
CONCLUSION: Application of OCTA for the evaluation of microvasculature in SLE patients may be useful in subclinical changes.

Entities:  

Keywords:  Hydroxychloroquine; Optical coherence tomography; Optical coherence tomography angiography; Subclinical retinal changes; Systemic lupus erythematosus

Mesh:

Year:  2020        PMID: 32851556     DOI: 10.1007/s10792-020-01561-8

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  22 in total

Review 1.  Ocular manifestations in systemic lupus erythematosus.

Authors:  Sukhum Silpa-archa; Joan J Lee; C Stephen Foster
Journal:  Br J Ophthalmol       Date:  2015-04-22       Impact factor: 4.638

2.  Choroidal Thickness in Patients with Systemic Lupus Erythematosus Analyzed by Spectral-domain Optical Coherence Tomography.

Authors:  Hasan Altinkaynak; Necati Duru; Betül Seher Uysal; Şükran Erten; Piraye Zeynep Kürkcüoğlu; Nilay Yüksel; Zeynep Duru; Nurullah Çağıl
Journal:  Ocul Immunol Inflamm       Date:  2015-07-08       Impact factor: 3.070

3.  Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.

Authors:  Min Gyu Lee; Sang Jin Kim; Don-Il Ham; Se Woong Kang; Changwon Kee; Jaejoon Lee; Hoon-Suk Cha; Eun-Mi Koh
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-25       Impact factor: 4.799

Review 4.  Vascular changes of the retina and choroid in systemic lupus erythematosus: pathology and pathogenesis.

Authors:  Tapas C Nag; Shashi Wadhwa
Journal:  Curr Neurovasc Res       Date:  2006-05       Impact factor: 1.990

5.  Retinal nerve fiber layer and macular thinning in systemic lupus erythematosus: an optical coherence tomography study comparing SLE and neuropsychiatric SLE.

Authors:  G Y Liu; T O Utset; J T Bernard
Journal:  Lupus       Date:  2015-04-16       Impact factor: 2.911

6.  Acute lupus choroidopathy: multimodal imaging and differential diagnosis from central serous chorioretinopathy.

Authors:  Murat Hasanreisoglu; Gokcen D Gulpinar Ikiz; Hamit Kucuk; Ozkan Varan; Sengul Ozdek
Journal:  Int Ophthalmol       Date:  2017-01-03       Impact factor: 2.031

7.  Choroidopathy in patients with systemic lupus erythematosus with or without nephropathy.

Authors:  Veronica Baglio; Magda Gharbiya; Corrado Balacco-Gabrieli; Tommaso Mascaro; Concetta Gangemi; Manuela Di Franco; Valentina Pistolesi; Santo Morabito; Gabriella Pecci; Alessandro Pierucci
Journal:  J Nephrol       Date:  2011 Jul-Aug       Impact factor: 3.902

8.  Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Authors:  Michael F Marmor; Ulrich Kellner; Timothy Y Y Lai; Ronald B Melles; William F Mieler
Journal:  Ophthalmology       Date:  2016-03-16       Impact factor: 12.079

Review 9.  Systemic lupus erythematosus and ocular involvement: an overview.

Authors:  Rosanna Dammacco
Journal:  Clin Exp Med       Date:  2017-12-14       Impact factor: 3.984

10.  Ocular manifestations of systemic lupus erythematosus: a review of the literature.

Authors:  Neal V Palejwala; Harpreet S Walia; Steven Yeh
Journal:  Autoimmune Dis       Date:  2012-07-02
View more
  1 in total

1.  Macular and peripapillary vessel density alterations in a large series of patients with systemic lupus erythematosus without ocular involvement.

Authors:  Sevgi Subasi; Kubra Demirci Kucuk; Senar San; Ayse Cefle; Ecem Onder Tokuc; Sibel Balci; Ayten Yazici
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-06       Impact factor: 3.535

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.